Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Feb;10(1):30-34.
doi: 10.1007/s13730-020-00510-9. Epub 2020 Jul 25.

A case of latent heterozygous Fabry disease in a female living kidney donor candidate

Affiliations
Case Reports

A case of latent heterozygous Fabry disease in a female living kidney donor candidate

Masato Minami et al. CEN Case Rep. 2021 Feb.

Abstract

A 52-year-old woman had been found to have hematuria at her annual checkup 5 years in a row. She hoped to donate her kidney to her husband, so we performed a percutaneous kidney biopsy at our department. It was difficult for us to detect apparent abnormalities under a light microscopic examination, and she was determined to meet the eligibility criteria for living kidney transplantation. However, the sample for electron microscopy was not evaluated before kidney donation. She subsequently underwent living kidney transplantation as a donor. A 1-h biopsy revealed swelling and obvious vacuolation of the glomerular podocytes, which were characteristic of Fabry disease. Her medical history and examinations were reviewed. No findings or episodes were observed. Pre-donation electronmicroscopy revealed numerous zebra bodies in the podocytes. A definite diagnosis of heterozygous Fabry disease was made based on the GLA gene mutation despite the normal range of leukocyte α-Gal A activity. Based on the pathological deposition of GL-3, chaperone therapy was initiated to suppress the progression of organ damage. In this case, we could not confirm a diagnosis of Fabry disease despite performing a renal biopsy prior to kidney donation. Kidney donor candidates may sometimes have factors that cannot be assumed based on medical or family history. Thus, it is important to perform a renal biopsy before kidney donation when necessary, and to always conduct a detailed evaluation including electron microscopy.

Keywords: Chaperone therapy; GLA gene mutation; Heterozygous Fabry disease; Kidney transplantation; Migalastat; α-Galactosidase A.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
a, c, d Renal pathology prior to kidney donation; b a 1-h biopsy. a No apparent change was detected in the glomeruli under a light microscopic examination before kidney donation (PAS staining × 400). b A 1-h biopsy revealed remarkable swelling and obvious vacuolation of the glomerular podocytes (PAS staining × 400). c Pre-donation electron microscopy revealed numerous zebra bodies in the podocytes (× 3000). d Basement membrane thinning (180 nm) was observed in part of the specimen (Arrowhead). Scale bars 2 μm

References

    1. Brady RO, Gal AE, Bradley RM, Martensson E, Warshaw AL, Laster L. Enzymatic defect in Fabry’s disease. N Engl J Med. 1967;27:1163–1167. doi: 10.1056/NEJM196705252762101. - DOI - PubMed
    1. Kint JA. Fabry’s disease: alpha-galactosidase deficiency. Science. 1970;167:1268–1269. doi: 10.1126/science.167.3922.1268. - DOI - PubMed
    1. Germain DP. Fabry disease. Orphanet J Rare Dis. 2010;5:30. doi: 10.1186/1750-1172-5-30. - DOI - PMC - PubMed
    1. MacDermot KD, Holmes A, Miners AH, Rowland HS. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males. J Med Genet. 2001;38(11):750–760. doi: 10.1136/jmg.38.11.750. - DOI - PMC - PubMed
    1. MacDermot KD, Holmes A, Miners AH, Rowland HS. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet. 2001;38(11):769–775. doi: 10.1136/jmg.38.11.769. - DOI - PMC - PubMed

Publication types

MeSH terms